Etanercept and adalimumab are both recommended to be available as routine commissioning treatment options for deficiency of adenosine deaminase type 2 (DADA2) within the criteria set out in these ...

The clinical features of MAS overlap with those of active sJIA, complicating early diagnosis and treatment. We evaluated adenosine deaminase 2 (ADA2), a protein of unknown function released ...

(B) The overall design of DRAM, DRAM mut and Deaminase system. (F) Screening process for DRAM-seq assays and principles for screening high-confidence genes. (G) The pie chart shows the distribution of ...

Development of DRAM system for m 5 C detection. (A) Schematic diagram of the DRAM assay. DRAM, DRAM mut and Deaminase system were transfected into HEK293T cells separately. After DRAM transfection, ...

Collaboration Revenue: There was $2.3 million of collaboration revenue for the year ended December 31, 2024, as compared to no collaboration revenue for the year ended December 31, 2023. The increase ...

After hours: March 18 at 5:42:05 PM EDT Loading Chart for ROIV ...

Hyperuricemia (HU) is a metabolic disorder characterized by elevated uric acid (UA) levels in the bloodstream, commonly diagnosed when UA levels ...

Italian biomedical charity Fondazione Telethon, which is focused on rare genetic diseases, revealed it has submitted a ...

KRRO-110 is the first RNA editing development candidate from Korro’s proprietary OPERA TM platform and is currently being evaluated in the Phase 1/2a REWRITE clinical study for AATD. Dosing of the ...

Axiomer™ ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program ...

Add a description, image, and links to the deep-mutational-scanning topic page so that developers can more easily learn about it.

Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on ...